আয়ার্লণ্ড -
ইংরেজি -
HPRA (Health Products Regulatory Authority)
warfant 5 mg tablets
mercury pharmaceuticals (ireland) ltd - warfarin sodium - tablet - 5 milligram(s) - vitamin k antagonists; warfarin
আয়ার্লণ্ড -
ইংরেজি -
HPRA (Health Products Regulatory Authority)
warfant 3 mg tablets
mercury pharmaceuticals (ireland) ltd - warfarin sodium - tablet - 3 milligram(s) - vitamin k antagonists; warfarin
আয়ার্লণ্ড -
ইংরেজি -
HPRA (Health Products Regulatory Authority)
warfarin rosemont 1 mg/1 ml oral suspension
rosemont pharmaceuticals ltd - warfarin sodium - oral suspension - 1 milligram(s)/millilitre - vitamin k antagonists; warfarin
আয়ার্লণ্ড -
ইংরেজি -
HPRA (Health Products Regulatory Authority)
zepholin s.r. 200 milligram prolonged release capsules
astellas pharma co. ltd - theophylline - prolonged release capsules - 200 milligram - xanthines
আয়ার্লণ্ড -
ইংরেজি -
HPRA (Health Products Regulatory Authority)
zepholin s.r. 100 milligram prolonged release capsules
astellas pharma co. ltd - theophylline - prolonged release capsules - 100 milligram - xanthines
আয়ার্লণ্ড -
ইংরেজি -
HPRA (Health Products Regulatory Authority)
zepholin s.r. 350 milligram prolonged release capsules
astellas pharma co. ltd - theophylline - prolonged release capsules - 350 milligram - xanthines
আয়ার্লণ্ড -
ইংরেজি -
HPRA (Health Products Regulatory Authority)
warfarin teva 0.5mg tablets
sun pharmaceutical industries europe b.v. - warfarin sodium clathrate - tablet - 0.5 milligram(s) - vitamin k antagonists; warfarin - antithrombotic agent (vitamin k antagonist) - it is indicated for the prophylaxis of venous thrombosis and pulmonary embolism, and for use in the treatment of these conditions to prevent their extensiona and for the prophylaxis of systemic embolisation in patients with rheumatic heart disease and atrial fibrillation.
আয়ার্লণ্ড -
ইংরেজি -
HPRA (Health Products Regulatory Authority)
warfarin teva 1 mg tablets
sun pharmaceutical industries europe b.v. - warfarin sodium clathrate - tablet - 1 milligram(s) - vitamin k antagonists; warfarin - antithrombotic agent (vitamin k antagonist) - it is indicated for the prophylaxis of venous thrombosis and pulmonary embolism, and for use in the treatment of these conditions to prevent their extension and for the prophylaxis of systemic embolisation in patients with rheumatic heart disease and atrial fibrillation.
আয়ার্লণ্ড -
ইংরেজি -
HPRA (Health Products Regulatory Authority)
warfarin teva 2 mg tablets
sun pharmaceutical industries europe b.v. - warfarin sodium clathrate - tablet - 2 milligram(s) - vitamin k antagonists; warfarin - antithrombotic agent (vitamin k antagonist) - it is indicated for the prophylaxis of venous thrombosis and pulmonary embolism, and for use in the treatment of these conditions to prevent their extension and for the prophylaxis of systemic embolisation in patients with rheumatic heart disease and atrial fibrillation.
আয়ার্লণ্ড -
ইংরেজি -
HPRA (Health Products Regulatory Authority)
warfarin teva 2.5 mg tablets
sun pharmaceutical industries europe b.v. - warfarin sodium clathrate - tablet - 2.5 milligram(s) - vitamin k antagonists; warfarin - antithrombotic agent (vitamin k antagonist) - it is indicated for the prophylaxis of venous thrombosis and pulmonary embolism, and for use in the treatment of these conditions to prevent their extension and for the prophylaxis of systemic embolisation in patients with rheumatic heart disease and atrial fibrillation.